BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//European Brain Council (EBC) - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:European Brain Council (EBC)
X-ORIGINAL-URL:https://www.braincouncil.eu
X-WR-CALDESC:Events for European Brain Council (EBC)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211003
DTEND;VALUE=DATE:20211008
DTSTAMP:20260415T221903
CREATED:20201209T093048Z
LAST-MODIFIED:20201209T093048Z
UID:26465-1633219200-1633651199@www.braincouncil.eu
SUMMARY:21st European Congress of Neurosurgery
DESCRIPTION:The European Association of Neurosurgical Societies (EANS) is both an independent federation of European national neurosurgical societies and a fast-developing association of individual neurosurgeons from around the world. \nWe are a professional community whose aim is to enhance the quality of neurosurgical patient care through training\, education and research. A key way in which we fulfil this objective is by facilitating the exchange of scientific information at the highest level through the organisation of meetings\, symposia and educational courses – with the annual Congress as our flagship event.\n\n\n\nWebsite: http://www.eans.org/events/
URL:https://www.braincouncil.eu/event/21st-european-congress-of-neurosurgery/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211006T143000
DTEND;TZID=UTC:20211006T170000
DTSTAMP:20260415T221903
CREATED:20210920T085715Z
LAST-MODIFIED:20210920T085815Z
UID:31392-1633530600-1633539600@www.braincouncil.eu
SUMMARY:Third European Patient Advocacy Summit – Inclusion of the Patient Voice in HTA
DESCRIPTION:EBC will be present at the upcoming third European Patient Advocacy Summit\, organised by Pfizer. The 2021 capability strengthening programme will focus on patient participation in Health Technology Assessment (HTA)\, with an emphasis on involvement in early stages of the process and the future impact of an EU-wide HTA. The summit will be organised in three sessions via Webex\, to be held on October 6\, 13 and 20 from 2.30pm to 5.00pm C.E.T.  \nHTAs assess whether a new pharmaceutical innovation works better\, equally well\, or worse than existing alternatives\, while also considering its cost implications for the patient and impact on healthcare systems. As patients know what it is like to live with a disease and have the needed experiential knowledge on existing treatments and the desirability of innovations\, patient involvement is crucial at an early stage to ensure the full integration of patient perspective into HTA outcomes. This includes involvement in early dialogues\, working to identify technologies\, up to the development of the assessment by helping to set the scope and formulate research questions. However\, the type and level of patient involvement in early dialogue and assessments is varied across Europe\, reflecting the different rationale\, motivation and approach applied in each country. \nSuch differences aim to be tackled within the soon-to be adopted regulation for an EU-wide HTA\, as Member States will be called out to better cooperate\, work towards joint clinical assessments and identify emerging health technologies together. It’s important that patient organisations understand the implications of this new legislative framework on their engagement activities\, to best approach and integrate themselves within this complex\, yet vital HTA process. \nWith this in mind\, this Summit aims to empower your voice as a patient organisation in your national and pan-EU HTA processes\, by helping you to strengthen the advocacy skills needed to participate. Practical workshop sessions will recap the importance of patient participation\, provide an overview of the significance of the upcoming EU-wide HTA legislation\, explain where early dialogues and assessments fit into the overall HTA process and approaches to achieving effective patient input and practical examples of best practice. \nEBC will be represented by its Executive Director\, Frédéric Destrebecq\, presenting “The patient voice is at the core of Europe’s rapidly evolving health policy landscape”.
URL:https://www.braincouncil.eu/event/third-european-patient-advocacy-summit-inclusion-of-the-patient-voice-in-hta/
END:VEVENT
END:VCALENDAR